Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.4230 (-7.64%) ($0.4230 - $0.4230) on Mon. Apr. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.78% (three month average) | RSI | 48 | Latest Price | $0.4230(-7.64%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC advances 4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) EWI(58%) PAVE(58%) XAR(50%) IPO(49%) KWEB(49%) | Factors Impacting ANPC price | ANPC will decline at least -5.39% in a week (0% probabilities). BNDX(-34%) BND(-23%) SHY(-19%) VCSH(-18%) TIP(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.39% (StdDev 10.78%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.45 | 5 Day Moving Average | $0.47(-10%) | 10 Day Moving Average | $0.45(-6%) | 20 Day Moving Average | $0.45(-6%) | To recent high | -63.2% | To recent low | 7.9% | Market Cap | $4m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |